Drug intelligence / Profile preview

Xin'an Capsule

Development stage: Unknown
Lead developer: Modern Chinese Medicine Group
Administration: Oral

Overview

Xin'an Capsule (心安胶囊) is a traditional Chinese medicine (TCM) herbal formulation developed and marketed by Modern Chinese Medicine Group (specifically through its subsidiary Chengde Yushi Jindan Pharmaceutical). It is an oral capsule indicated for the treatment of cardiovascular diseases and various heart conditions. As a TCM product, it is designed to provide therapeutic benefits through holistic physiological pathways, often associated with qi-blood tonification or circulation enhancement, rather than targeting a single molecular pathway. In 2019, the developer entered into a collaboration with Chengde Medical University to optimize the production processes and enhance the quality standards of the formulation. The product is currently approved and commercially available in China.

Brand names: Xin'an Capsule
Other names: 心安胶囊Heart Wellness Capsule

Beyond the preview

Go deeper on Xin'an Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xin'an Capsule.

Explore the full profile